Preven Emergency Contraceptive Kit is a drug owned by Teva Branded Pharmaceutical Products R And D Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Dec 05, 2020. Details of Preven Emergency Contraceptive Kit's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US6156742 | Emergency contraceptive kit |
Dec, 2020
(3 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Preven Emergency Contraceptive Kit is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Preven Emergency Contraceptive Kit's family patents as well as insights into ongoing legal events on those patents.
Preven Emergency Contraceptive Kit's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Preven Emergency Contraceptive Kit's generic launch date based on the expiry of its last outstanding patent is estimated to be Dec 05, 2020 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Preven Emergency Contraceptive Kit Generic API suppliers:
Ethinyl Estradiol; Levonorgestrel is the generic name for the brand Preven Emergency Contraceptive Kit. 16 different companies have already filed for the generic of Preven Emergency Contraceptive Kit, with Xiromed having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Preven Emergency Contraceptive Kit's generic
Alternative Brands for Preven Emergency Contraceptive Kit
Preven Emergency Contraceptive Kit which is used for emergency contraception after unprotected sex., has several other brand drugs using the same active ingredient (Ethinyl Estradiol; Levonorgestrel). Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | ||||
|---|---|---|---|---|---|
| Agile |
| ||||
| Avion Pharms |
| ||||
| Teva Branded Pharm |
| ||||
| Wyeth Pharms Inc |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Ethinyl Estradiol; Levonorgestrel, Preven Emergency Contraceptive Kit's active ingredient. Check the complete list of approved generic manufacturers for Preven Emergency Contraceptive Kit
About Preven Emergency Contraceptive Kit
Preven Emergency Contraceptive Kit is a drug owned by Teva Branded Pharmaceutical Products R And D Inc. It is used for emergency contraception after unprotected sex. Preven Emergency Contraceptive Kit uses Ethinyl Estradiol; Levonorgestrel as an active ingredient. Preven Emergency Contraceptive Kit was launched by Teva Branded Pharm in 1998.
Approval Date:
Preven Emergency Contraceptive Kit was approved by FDA for market use on 01 September, 1998.
Active Ingredient:
Preven Emergency Contraceptive Kit uses Ethinyl Estradiol; Levonorgestrel as the active ingredient. Check out other Drugs and Companies using Ethinyl Estradiol; Levonorgestrel ingredient
Treatment:
Preven Emergency Contraceptive Kit is used for emergency contraception after unprotected sex.
Dosage:
Preven Emergency Contraceptive Kit is available in tablet form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 0.05MG;0.25MG | TABLET | Discontinued | ORAL |